Form 4: Linda Gooden Reports Stock Transactions in NeueHealth, Inc.

Sentiment:

SEC Form 4 Filing


Director Linda Gooden reports acquisition and disposal of NeueHealth, Inc. common stock and restricted stock units.

Summary

  • Linda Gooden, a director of NeueHealth, Inc., filed a Form 4 with the SEC.
  • The report details transactions involving common stock and restricted stock units.
  • On May 12, 2024, 4,755 shares of common stock were disposed of at a price of $0.
  • Following this transaction, Gooden beneficially owns 99,864 shares of common stock.
  • On the same date, 4,755 restricted stock units vested and were converted to common stock.
  • On May 13, 2024, 10,500 restricted stock units were acquired, vesting on May 13, 2025.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting stock transactions. It doesn't inherently convey positive or negative sentiment.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, as required by SEC regulations. It provides transparency to the market regarding the trading activities of key personnel.

Stakeholder Impact

  • The filing provides transparency to shareholders regarding insider trading activity.

Key Dates

DateDescription
05/12/20244,755 shares of common stock disposed of; 4,755 restricted stock units vested.
05/13/202410,500 restricted stock units acquired, vesting on May 13, 2025.
05/14/2024Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.